2018年第23届欧洲血液学协会年会(EHA)

2018-05-30 MedSci MedSci原创

欧洲血液学协会年会(EHA年会)是全球血液学领域规模最大的国际会议之一,大会主题涵盖了血液学研究的所有方面,汇集了来自全球100多个国家的10000余名专业人士与会,一起分享探讨有关血液学的创新理念及最新的科学和临床研究成果。



会议时间:2018年6月14-17日

会议地点:瑞典 斯德哥尔摩/Stockholm

会议简介:

欧洲血液学协会(EHA)成立于1992年,是致力于促进血液学临床实践、研究和教育的非营利性组织,是国际上最大的血液学知识独立提供商之一,目前在全球100多个国家拥有超过4400名成员。

欧洲血液学协会年会(EHA年会)是全球血液学领域规模最大的国际会议之一,大会主题涵盖了血液学研究的所有方面,汇集了来自全球100多个国家的10000余名专业人士与会,一起分享探讨有关血液学的创新理念及最新的科学和临床研究成果。

Congress objectives:

The EHA Annual Congress is a forum for original unpublished data, for sharing ideas about hematological innovation, as well as for disseminating evidence-based knowledge of primary clinical relevance. Hematologists and affiliated professionals will be able to:

Enhance their knowledge of evidence-based approaches to diagnosis and treatment for hematologic diseases.

Access the latest results on clinical and translational research in hematologic disorders.

Be updated on emerging innovative techniques, diagnostic tools and risk-assessment strategies in hematology and its subspecialties.

Communicate, collaborate and network with representatives of a large international audience – medical professionals, national hematology societies, patient groups, medical industry and the media.

关键日期:


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1339084, encodeId=5ed31339084db, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466302, encodeId=e4fd146630289, content=<a href='/topic/show?id=765c8925904' target=_blank style='color:#2F92EE;'>#血液学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89259, encryptionId=765c8925904, topicName=血液学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67c86798320, createdName=hxq78318, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521898, encodeId=f03d1521898c2, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320036, encodeId=a918320036e0, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Wed May 30 19:39:11 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1339084, encodeId=5ed31339084db, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466302, encodeId=e4fd146630289, content=<a href='/topic/show?id=765c8925904' target=_blank style='color:#2F92EE;'>#血液学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89259, encryptionId=765c8925904, topicName=血液学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67c86798320, createdName=hxq78318, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521898, encodeId=f03d1521898c2, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320036, encodeId=a918320036e0, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Wed May 30 19:39:11 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1339084, encodeId=5ed31339084db, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466302, encodeId=e4fd146630289, content=<a href='/topic/show?id=765c8925904' target=_blank style='color:#2F92EE;'>#血液学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89259, encryptionId=765c8925904, topicName=血液学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67c86798320, createdName=hxq78318, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521898, encodeId=f03d1521898c2, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320036, encodeId=a918320036e0, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Wed May 30 19:39:11 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
    2018-06-01 qjddjq
  4. [GetPortalCommentsPageByObjectIdResponse(id=1339084, encodeId=5ed31339084db, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1466302, encodeId=e4fd146630289, content=<a href='/topic/show?id=765c8925904' target=_blank style='color:#2F92EE;'>#血液学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89259, encryptionId=765c8925904, topicName=血液学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67c86798320, createdName=hxq78318, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521898, encodeId=f03d1521898c2, content=<a href='/topic/show?id=f83866137f' target=_blank style='color:#2F92EE;'>#EHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6613, encryptionId=f83866137f, topicName=EHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937d11405368, createdName=qjddjq, createdTime=Fri Jun 01 05:48:00 CST 2018, time=2018-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320036, encodeId=a918320036e0, content=mark, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Wed May 30 19:39:11 CST 2018, time=2018-05-30, status=1, ipAttribution=)]
    2018-05-30 smartxiuxiu

    mark

    0

相关资讯

2018 EHA抢先看:Daratumumab+VMP方案治疗高龄MM患者,ORR率达88%

欧洲血液学协会(EHA)成立于1992年,是全球血液学领域规模最大的国际会议之一。2018年6月14日-6月17日,第23届EHA将于瑞典-斯德哥尔摩举行。在本次EHA会议上将迎来多项血液肿瘤领域的重磅研究,肿瘤资讯带您先睹为快。

2018EHA抢先看:一种新方法:或有助于优化CLL伊布替尼联合治疗策略

欧洲血液学协会(EHA)成立于1992年,是全球血液学领域规模最大的国际会议之一。2018年6月14日-6月17日,第23届EHA将于瑞典-斯德哥尔摩举行。在本次EHA会议上将迎来多项血液肿瘤领域的重磅研究,肿瘤资讯带您先睹为快。

EHA 2013:2013传递多发性骨髓瘤治疗新理念

2013年欧洲血液病学会(EHA)年会在瑞典斯德哥尔摩举行。大会对包括多发性骨髓瘤(MM)在内的多种血液系统疾病进行了深入介绍和讨论。本文就本届年会在初治和复发/难治MM方面的进展加以摘述,以期对临床医师有所启发。 初治MM患者的治疗进展 初治适合移植患者用药 近几年来移植前诱导性化疗受到广泛关注。在本届年会上,一项包含4项随机对照Ⅲ期临床研究的荟萃分析(n=1572)显示,含硼替佐米方案诱

2018EHA抢先看:年龄或许不是问题!高龄DLBCL患者也可从蒽环类方案中获益

欧洲血液学协会(EHA)成立于1992年,是全球血液学领域规模最大的国际会议之一。2018年6月14日-6月17日,EHA将于瑞典-斯德哥尔摩举行。在本次EHA会议上将迎来多项血液肿瘤领域的重磅研究,肿瘤资讯带您先睹为快。

EHA 2012:深度报道急性髓性白血病诊治

17届欧洲血液病学会(EHA)年会于6月14~17日在荷兰召开,本届年会续演历届EHA年会的精彩,可谓盛况空前,来自全球的近万名参会代表也获益 匪浅。急性髓性白血病(AML)的相关研究已成为每年大会交流最受关注的内容,现就本次年会中围绕AML的分子生物学特征、治疗、造血干细胞及造血微环境 的相关研究进展介绍如下。 【分子生物学特征与预后的关系】      &nbs

EHA 2013:陈文明:传递多发性骨髓瘤治疗新理念

 陈文明教授6月13-16日,2013年欧洲血液病学会(EHA)年会在瑞典斯德哥尔摩举行。大会对包括多发性骨髓瘤(MM)在内的多种血液系统疾病进行了深入介绍和讨论。本文就本届年会在初治和复发/难治MM方面的进展加以摘述,以期对临床医师有所启发。一、初治MM患者的治疗进展初治适合移植患者用药近几年来移植前诱导性化疗受到广泛关注。在本届年会上,一项包含4项随机对照Ⅲ期临床研究的荟萃分析(n=